Daniel Meuser
Trade Performance Intelligence
Score: 4/10Performance calculated from trade date to most recent market close. Real-time stock data from Financial Modeling Prep. This is not financial advice.
Stock Price at Trade vs. Today
Real market data showing how each stock moved since the congress member traded it.
Suspicious Timing Detected
5 flagsDaniel Meuser sold $50K-$100K in $GOOGL on 2025-02-11, 135 days before the STOP CSAM Act of 2025 (S1829) advanced to the Senate Legislative Calendar, a bill that directly increases liability for online platforms.
Daniel Meuser sold $15K-$50K in $AAPL on 2025-02-11, 156 days before the Price Gouging Prevention Act of 2025 (HR4528) was introduced, which could limit corporate profitability for large-cap companies.
Daniel Meuser sold $50K-$100K in $GOOGL on 2025-02-11, 160 days before the AI Accountability and Personal Data Protection Act (S2367) was introduced, which creates a Federal tort for data exploitation.
These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
| Type | Ticker | Asset | Amount | Trade Price | Current | Change | Date |
|---|---|---|---|---|---|---|---|
| PARTIAL SELL | $NVDA | NVIDIA Corporation - Common Stock | $250K-$500K | — | — | — | Feb 11, 2025 |
| SELL | $GOOGL | Alphabet Inc. - Class A Common Stock | $50K-$100K | — | — | — | Feb 11, 2025 |
| SELL | $AAPL | Apple Inc. - Common Stock | $15K-$50K | — | — | — | Feb 11, 2025 |
| SELL | $QCOM | QUALCOMM Incorporated - Common Stock | $15K-$50K | — | — | — | Feb 11, 2025 |
| SELL | $V | Visa Inc. | $15K-$50K | — | — | — | Feb 11, 2025 |
| SELL | $AMGN | Amgen Inc. - Common Stock | $1K-$15K | — | — | — | Feb 11, 2025 |
| SELL | $APTV | Aptiv PLC Ordinary Shares | $1K-$15K | — | — | — | Feb 11, 2025 |
| SELL | $MSFT | Microsoft Corporation - Common Stock | $1K-$15K | — | — | — | Feb 11, 2025 |
| SELL | $MDLZ | Mondelez International, Inc. - Class A Common Stock | $1K-$15K | — | — | — | Feb 11, 2025 |
Connected Legislative Activity
10 signalsThese bills and contracts share tickers or sectors with this filing's trades.
Treat and Reduce Obesity Act of 2025
The Treat and Reduce Obesity Act of 2025 (S.1973) is in early legislative stages, aiming to expand Medicare coverage for obesity treatments, including GLP-1 agonists and intensive behavioral therapy. This bill, if enacted, would significantly increase the total addressable market for pharmaceutical companies producing obesity drugs and manufacturers of related medical devices. Companies like Eli Lilly and Company ($LLY) and Novo Nordisk A/S ($NVO) are positioned to benefit from this potential market expansion.
Taiwan Non-Discrimination Act of 2025
The Taiwan Non-Discrimination Act of 2025 requires the U.S. Treasury to advocate for Taiwan's inclusion and equitable treatment within the International Monetary Fund (IMF). This bill does not directly allocate funds or impose new regulations on U.S. companies, but it signals continued U.S. support for Taiwan's international standing, which indirectly benefits companies with significant operations or supply chain ties to Taiwan.
MAPWaters Act of 2025
The MAPWaters Act of 2025 mandates federal agencies to standardize and publish geospatial data for public waterways. This creates a new market for data management and mapping services, benefiting companies specializing in GIS and mapping technologies.
Small Biotech Innovation Act
The Small Biotech Innovation Act (HR3731) is in an early legislative stage, aiming to exempt research and development-intensive small biotech manufacturers from Medicare drug price negotiations. While the bill could protect future revenue streams for qualifying small biotech firms, there is no direct market reaction evident in the provided stock data for either large or small biotech firms.
Price Gouging Prevention Act of 2025
The Price Gouging Prevention Act of 2025 directly limits corporate profitability for large-cap companies during 'exceptional market shock' events by mandating pre-shock margin maintenance. This legislation increases regulatory risk and caps potential upside for companies with significant market power across all sectors, leading to decreased profitability during crises. All major corporations face reduced profit potential and increased compliance costs.
AI Accountability and Personal Data Protection Act
The 'AI Accountability and Personal Data Protection Act' (S.2367) introduces a Federal tort for data exploitation without prior consent, including AI training, directly increasing compliance costs and litigation risk for technology companies. Meta Platforms ($META) has experienced a 30-day decline of 13.25%, Alphabet ($GOOGL) a 0.3% decline, Amazon ($AMZN) a 2.81% decline, Microsoft ($MSFT) a 9.2% decline, and Salesforce ($CRM) an 8.12% decline, while NVIDIA ($NVDA) and IBM ($IBM) saw smaller declines of 3.11% and 3.82% respectively over the same period.
Access Technology Affordability Act of 2025
The Access Technology Affordability Act of 2025 introduces a refundable tax credit of up to $2,000 every three years for the purchase of qualified access technology for blind individuals. This directly increases consumer purchasing power for specific technology products, creating a new demand channel for companies in the assistive technology space.
Small Nonprofit Retirement Security Act of 2025
The Small Nonprofit Retirement Security Act of 2025 expands tax credits for retirement plan startup costs and auto-enrollment to tax-exempt small employers, directly increasing the total addressable market for financial services and payroll processing companies. This creates a new revenue stream for providers of retirement plan administration, payment processing, and financial data services.
Blue Shield Privacy Act of 2025
The Blue Shield Privacy Act of 2025, HR4828, expands privacy protections to include biometric data, license plate numbers, workplace/school addresses, and GPS coordinates. This bill, currently in its early stages, creates new compliance burdens for companies collecting and processing such data. The broad scope indicates potential increased operational costs for major data-driven companies.
STOP CSAM Act of 2025
The STOP CSAM Act of 2025 (S.1829) has advanced to the Senate Legislative Calendar, increasing the likelihood of passage. This bill directly increases liability and compliance costs for online platforms, which will reduce profit margins for major online service providers. Affected companies, including Alphabet, Meta Platforms, Microsoft, Amazon, Twilio, Verizon, and AT&T, face increased operational expenses due to mandated content moderation and reporting systems.
Live Charts
Other Filings by Daniel Meuser
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.